Cargando…

Colistin Resistance and Management of Drug Resistant Infections

Colistin resistance is a globalized sensible issue because it has been considered a drug of the last-line resort to treat drug-resistant bacterial infections. The product of the mobilized colistin resistance (mcr) gene and its variants are the significant causes of colistin resistance, which is emer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Juhi, Sharma, Divakar, Singh, Amit, Sunita, Kumari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759378/ https://www.ncbi.nlm.nih.gov/pubmed/36536900 http://dx.doi.org/10.1155/2022/4315030

Ejemplares similares

Exploring the Mystery of Angiotensin-Converting Enzyme II (ACE2) in the Battle against SARS-CoV-2
por: Sharma, Divakar, et al.
Publicado: (2021)

Management of multi drug resistant endogenous Klebsiella pneumoniae endophthalmitis with intravitreal and systemic colistin
por: Dogra, Mohit, et al.
Publicado: (2018)

Molecular mechanisms of colistin- and multidrug-resistance in bacteria among patients with hospital-acquired infections
por: Khurana, Surbhi, et al.
Publicado: (2023)

An overview of colistin resistance, mobilized colistin resistance genes dissemination, global responses, and the alternatives to colistin: A review
por: Gharaibeh, Mohammad H., et al.
Publicado: (2019)

Colistin Resistance in Aeromonas spp.
por: Gonzalez-Avila, Luis Uriel, et al.
Publicado: (2021)

Potential Alternative Strategy against Drug Resistant Tuberculosis: A Proteomics Prospect
por: Sharma, Divakar, et al.
Publicado: (2018)

Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India
por: Taneja, Neelam, et al.
Publicado: (2011)

Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria
por: Witherell, Kaitlin S., et al.
Publicado: (2020)

Colistin Resistance Among Multiple Sequence Types of Klebsiella pneumoniae Is Associated With Diverse Resistance Mechanisms: A Report From India
por: Azam, Mudsser, et al.
Publicado: (2021)

2433. Evaluation of Meropenem (MEM) in Combination With Colistin (COL) Against Colistin-Resistant Extensively Drug-Resistant (XRD) Gram-Negative Bacteria
por: Singh, Nivedita, et al.
Publicado: (2018)

Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
por: Huang, Po-Han, et al.
Publicado: (2022)

Investigating colistin drug resistance: The role of high-throughput sequencing and bioinformatics
por: Aruhomukama, Dickson, et al.
Publicado: (2019)

Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis
por: Swain, Shasank S., et al.
Publicado: (2020)

The Challenges and Successes of Dealing with the COVID-19 Pandemic in India
por: Sharma, Juhi, et al.
Publicado: (2021)

Transition of colistin dependence into colistin resistance in Acinetobacter baumannii
por: Lee, Ji-Young, et al.
Publicado: (2017)

M. tuberculosis Hypothetical Proteins and Proteins of Unknown Function: Hope for Exploring Novel Resistance Mechanisms as well as Future Target of Drug Resistance
por: Sharma, Divakar, et al.
Publicado: (2017)

Bacteriophage as a Novel Therapeutic Weapon for Killing Colistin-Resistant Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Bacteria
por: Mousavi, Seyed Mohammad, et al.
Publicado: (2021)

Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria
por: Peyclit, Lucie, et al.
Publicado: (2019)

Molecular mechanisms related to colistin resistance in Enterobacteriaceae
por: Aghapour, Zahra, et al.
Publicado: (2019)

Prevalence of the colistin resistance gene MCR-1 in colistin-resistant Klebsiella pneumoniae in Egypt
por: Abozahra, Rania, et al.
Publicado: (2023)

Is Africa ready for mobile colistin resistance threat?
por: Anyanwu, Madubuike Umunna, et al.
Publicado: (2021)

Recent progress on elucidating the molecular mechanism of plasmid-mediated colistin resistance and drug design
por: Kai, Jindan, et al.
Publicado: (2019)

Synergistic Effects of Capric Acid and Colistin against Colistin-Susceptible and Colistin-Resistant Enterobacterales
por: Liu, Yi-Yun, et al.
Publicado: (2022)

Global Burden of Colistin-Resistant Bacteria: Mobilized Colistin Resistance Genes Study (1980–2018)
por: Elbediwi, Mohammed, et al.
Publicado: (2019)

Editorial: Approaches to Address Resistance, Drug Discovery, and Vaccine Development in Mycobacterium tuberculosis: Challenges and Opportunities
por: Sharma, Sandeep, et al.
Publicado: (2022)

Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections
por: Gounden, Ronald, et al.
Publicado: (2009)

Management with colistin
por: Singh, Harkirat
Publicado: (2010)

Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis
por: Sharma, Divakar, et al.
Publicado: (2017)

Role of Bacterioferritin & Ferritin in M. tuberculosis Pathogenesis and Drug Resistance: A Future Perspective by Interactomic Approach
por: Sharma, Divakar, et al.
Publicado: (2017)

Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis
por: Huang, Chienhsiu, et al.
Publicado: (2022)

Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates
por: Trebosc, Vincent, et al.
Publicado: (2019)

The History of Colistin Resistance Mechanisms in Bacteria: Progress and Challenges
por: Hamel, Mouna, et al.
Publicado: (2021)

Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology
por: Novović, Katarina, et al.
Publicado: (2023)

Diabetes Might Augment the Severity of COVID-19: A Current Prospects
por: Sur, Jayeeta, et al.
Publicado: (2021)

Ursolic acid inhibits colistin efflux and curtails colistin resistant Enterobacteriaceae
por: Sundaramoorthy, Niranjana Sri, et al.
Publicado: (2019)

Combination of Colistin and Azidothymidine Demonstrates Synergistic Activity against Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae
por: Chang, Ya-Ting, et al.
Publicado: (2020)

In vitro activity of colistin mono- and combination therapy against colistin-resistant Acinetobacter baumannii, mechanism of resistance, and clinical outcomes of patients infected with colistin-resistant A. baumannii at a Thai university hospital
por: Lertsrisatit, Yongyut, et al.
Publicado: (2017)

Comparison of colistin monotherapy and non-colistin combinations in the treatment of multi-drug resistant Acinetobacter spp. bloodstream infections: A Multicenter retrospective analysis
por: Balkan, Ilker Inanc, et al.
Publicado: (2015)

An Approach to Measuring Colistin Plasma Levels Regarding the Treatment of Multidrug-Resistant Bacterial Infection
por: Pacheco, Tatiana, et al.
Publicado: (2019)

Once Versus Thrice Daily Colistin in Critically Ill Ptients with Multi-Drug Resistant Infections
por: Ghazaeian, Monireh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3apj17j7vi5f2l5sn1kjmf1b3f